Compound Detail
CHEMBL319111
LINOPIRDINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL319111 |
| Name | LINOPIRDINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | YEJCDKJIEMIWRQ-UHFFFAOYSA-N |
2
Targets
7
Activities
2
Assay Types
0
PK Parameters
12
Publications
4
Known Names
1
Indications
Molecular Properties
391.5
MW (Da)
4.88
ALogP
3
HBA
0
HBD
46.1
PSA (Ų)
0.49
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Attention Deficit Disorder with Hyperactivity
ATC Classification
N06BX09
linopirdine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 6 meas. best 5.1
EC50 1 meas. best 5.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Rattus norvegicus CHEMBL376 | EC50 | 5.35 | 5.35 | 4500.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.1 | 4.9833 | 7943.3 | 6 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 6 |
| 9804701 | 10.1021/jm9803424 | Rattus norvegicus | 5 |
| - | 10.6019/CHEMBL3301361 | ADMET | 3 |
| - | 10.1016/S0960-894X(00)80543-0 | Rattus norvegicus | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 8411006 | 10.1021/jm00072a009 | Rattus norvegicus | 1 |
| 8411006 | 10.1021/jm00072a009 | No relevant target | 1 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine